vs
Alector, Inc.（ALEC）与Xos, Inc.（XOS）财务数据对比。点击上方公司名可切换其他公司
Alector, Inc.的季度营收约是Xos, Inc.的1.2倍（$6.2M vs $5.2M），Xos, Inc.同比增速更快（-54.5% vs -88.5%），过去两年Xos, Inc.的营收复合增速更高（-35.7% vs -37.4%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
Xos, Inc.是一家美国制造商，专注于生产商用电动车辆以及移动式电动汽车充电桩。该公司扎根商用车电动化领域，为物流、货运等商业运输场景提供纯电动力解决方案与配套充电设备，助力商用车领域的低碳转型。
ALEC vs XOS — 直观对比
营收规模更大
ALEC
是对方的1.2倍
$5.2M
营收增速更快
XOS
高出34.0%
-88.5%
两年增速更快
XOS
近两年复合增速
-37.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $5.2M |
| 净利润 | — | $-9.8M |
| 毛利率 | — | -50.5% |
| 营业利润率 | — | -186.6% |
| 净利率 | — | -186.8% |
| 营收同比 | -88.5% | -54.5% |
| 净利润同比 | -1696.9% | 48.6% |
| 每股收益（稀释后） | — | $-0.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALECXOS
| Q4 25 | $6.2M | $5.2M | ||
| Q3 25 | $3.3M | $16.5M | ||
| Q2 25 | $7.9M | $18.4M | ||
| Q1 25 | $3.7M | $5.9M | ||
| Q4 24 | $54.2M | $11.5M | ||
| Q3 24 | $15.3M | $15.8M | ||
| Q2 24 | $15.1M | $15.5M | ||
| Q1 24 | $15.9M | $12.6M |
净利润ALECXOS
| Q4 25 | — | $-9.8M | ||
| Q3 25 | $-34.7M | $2.1M | ||
| Q2 25 | $-30.5M | $-7.5M | ||
| Q1 25 | $-40.5M | $-10.2M | ||
| Q4 24 | $-2.1M | $-19.0M | ||
| Q3 24 | $-42.2M | $-10.5M | ||
| Q2 24 | $-38.7M | $-9.7M | ||
| Q1 24 | $-36.1M | $-11.0M |
毛利率ALECXOS
| Q4 25 | — | -50.5% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 20.6% | ||
| Q4 24 | — | -32.4% | ||
| Q3 24 | — | 18.1% | ||
| Q2 24 | — | 13.1% | ||
| Q1 24 | — | 22.1% |
营业利润率ALECXOS
| Q4 25 | — | -186.6% | ||
| Q3 25 | -1153.6% | -42.4% | ||
| Q2 25 | -433.6% | -38.5% | ||
| Q1 25 | -1216.5% | -157.7% | ||
| Q4 24 | -13.4% | -127.0% | ||
| Q3 24 | -315.7% | -61.4% | ||
| Q2 24 | -302.4% | -73.2% | ||
| Q1 24 | -275.0% | -81.1% |
净利率ALECXOS
| Q4 25 | — | -186.8% | ||
| Q3 25 | -1063.4% | 12.9% | ||
| Q2 25 | -387.7% | -40.8% | ||
| Q1 25 | -1101.6% | -173.3% | ||
| Q4 24 | -3.8% | -165.4% | ||
| Q3 24 | -275.2% | -66.6% | ||
| Q2 24 | -256.4% | -62.2% | ||
| Q1 24 | -227.0% | -87.1% |
每股收益（稀释后）ALECXOS
| Q4 25 | — | $-0.76 | ||
| Q3 25 | $-0.34 | $0.22 | ||
| Q2 25 | $-0.30 | $-0.91 | ||
| Q1 25 | $-0.41 | $-1.26 | ||
| Q4 24 | $-0.02 | $-2.34 | ||
| Q3 24 | $-0.43 | $-1.32 | ||
| Q2 24 | $-0.40 | $-1.23 | ||
| Q1 24 | $-0.38 | $-1.80 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | $14.0M |
| 总债务越低越好 | $10.0M | — |
| 股东权益账面价值 | $30.6M | $23.3M |
| 总资产 | $293.2M | $60.4M |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALECXOS
| Q4 25 | $256.0M | $14.0M | ||
| Q3 25 | $291.1M | $14.1M | ||
| Q2 25 | $307.3M | $8.8M | ||
| Q1 25 | $354.6M | $4.8M | ||
| Q4 24 | $413.4M | $11.0M | ||
| Q3 24 | $457.2M | $8.4M | ||
| Q2 24 | $503.3M | $19.7M | ||
| Q1 24 | $562.1M | $46.2M |
总债务ALECXOS
| Q4 25 | $10.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALECXOS
| Q4 25 | $30.6M | $23.3M | ||
| Q3 25 | $57.7M | $31.1M | ||
| Q2 25 | $71.2M | $18.3M | ||
| Q1 25 | $94.6M | $24.8M | ||
| Q4 24 | $126.8M | $33.6M | ||
| Q3 24 | $118.9M | $50.8M | ||
| Q2 24 | $150.6M | $59.2M | ||
| Q1 24 | $178.9M | $67.8M |
总资产ALECXOS
| Q4 25 | $293.2M | $60.4M | ||
| Q3 25 | $335.3M | $73.8M | ||
| Q2 25 | $356.4M | $80.3M | ||
| Q1 25 | $408.3M | $87.7M | ||
| Q4 24 | $468.3M | $98.3M | ||
| Q3 24 | $516.0M | $120.5M | ||
| Q2 24 | $570.7M | $123.4M | ||
| Q1 24 | $635.5M | $135.0M |
负债/权益比ALECXOS
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $2.4M |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | — |
| 自由现金流率自由现金流/营收 | -2951.3% | — |
| 资本支出强度资本支出/营收 | 0.7% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-326.5M | — |
8季度趋势，按日历期对齐
经营现金流ALECXOS
| Q4 25 | $-184.0M | $2.4M | ||
| Q3 25 | $-32.5M | $3.1M | ||
| Q2 25 | $-49.0M | $4.6M | ||
| Q1 25 | $-60.8M | $-4.8M | ||
| Q4 24 | $-55.0M | $3.3M | ||
| Q3 24 | $-50.7M | $-11.5M | ||
| Q2 24 | $-62.8M | $-26.0M | ||
| Q1 24 | $-61.3M | $-14.6M |
自由现金流ALECXOS
| Q4 25 | $-184.1M | — | ||
| Q3 25 | $-32.5M | — | ||
| Q2 25 | $-49.1M | — | ||
| Q1 25 | $-60.8M | — | ||
| Q4 24 | $-55.2M | — | ||
| Q3 24 | $-50.9M | $-11.7M | ||
| Q2 24 | $-63.1M | $-26.1M | ||
| Q1 24 | $-61.9M | $-14.6M |
自由现金流率ALECXOS
| Q4 25 | -2951.3% | — | ||
| Q3 25 | -997.6% | — | ||
| Q2 25 | -623.0% | — | ||
| Q1 25 | -1655.0% | — | ||
| Q4 24 | -101.8% | — | ||
| Q3 24 | -332.1% | -73.9% | ||
| Q2 24 | -418.6% | -168.1% | ||
| Q1 24 | -389.3% | -115.7% |
资本支出强度ALECXOS
| Q4 25 | 0.7% | 0.0% | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.5% | 0.0% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 1.4% | 0.9% | ||
| Q2 24 | 2.2% | 0.8% | ||
| Q1 24 | 3.4% | 0.2% |
现金转化率ALECXOS
| Q4 25 | — | — | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
